Can You Get Inspire If You Have a Pacemaker?

Having a pacemaker does not automatically disqualify you from getting the Inspire upper airway stimulation system for obstructive sleep apnea. Published research on patients who have both devices shows the combination is feasible when surgeons take specific precautions, though the data comes from small studies and the overlap of these two patient populations is strikingly common. The details matter, and the planning involved is more involved than for someone without a cardiac device.

Why So Many Pacemaker Patients Have Sleep Apnea

The question of combining Inspire with a pacemaker comes up more than you might expect, because sleep apnea is remarkably common in people who already have pacemakers. A European multicenter study that performed polysomnography on pacemaker patients found that about 59% of them had sleep apnea syndrome, and roughly a fifth had severe cases with more than 30 breathing interruptions per hour.¹ Most of these patients had never been diagnosed. A separate study using newer-generation pacemaker diagnostics found sleep apnea in 74% of patients tested, with only snoring as a noticeable symptom in most cases.²

Even more conservative screening has put the prevalence of sleep-disordered breathing in pacemaker patients above 30%.³ The connection runs in both directions: sleep apnea stresses the heart through repeated drops in oxygen and surges in stress hormones, which can worsen the arrhythmias that led to the pacemaker in the first place. Meanwhile, the heart conditions treated by pacing, like heart failure and abnormal rhythms, share risk factors with sleep apnea. The upshot is that a large share of pacemaker patients could benefit from effective sleep apnea treatment, and when CPAP fails or is intolerable, Inspire becomes a natural consideration.

The Published Evidence on Having Both Devices

The largest published study on combining a hypoglossal nerve stimulator like Inspire with a cardiac implantable electronic device enrolled 14 patients. Nine had pacemakers, four had implantable cardioverter-defibrillators (ICDs), and one had a cardiac resynchronization therapy device. In every case, the Inspire system was implanted on the opposite side of the chest from the cardiac device. All the cardiac devices were programmed to bipolar sensing mode, and the Inspire stimulators were tested during surgery to confirm that neither unipolar nor bipolar stimulation caused any interference with the cardiac device’s ability to sense the heart’s electrical signals. Over the follow-up period, no episodes of oversensing were recorded on any of the cardiac devices.⁴

A more recent single-center study looked at ten patients with both Inspire and a cardiac device. The results were mostly reassuring but included an important exception: one patient with an Abbott dual-chamber pacemaker showed electrical interference, specifically inappropriate mode switching triggered by atrial noise. In that case, the Inspire generator sat on the right side of the chest while the pacemaker generator was on the left, so the devices were on opposite sides as recommended. The remaining nine patients showed stable sensing, consistent pacing thresholds, and no inappropriate therapy delivery.⁵

Taken together, these studies suggest that the combination can work safely for most patients, but they also show that the risk of device-device interaction is not zero. The total number of patients studied remains small, in the low twenties across both reports. That is enough to demonstrate feasibility, but not enough for anyone to guarantee that interference will never happen. This is a situation where the evidence is encouraging but still evolving.

How Surgeons Prevent the Devices From Interfering

The main concern with putting two implanted electrical devices in the same body is crosstalk: the electrical pulses from one device being picked up by the other and misinterpreted as a cardiac signal. If a pacemaker “sees” the Inspire’s stimulation pulses and mistakes them for heartbeats, it could inappropriately withhold pacing when you actually need it. If an ICD misreads Inspire’s output as a dangerous heart rhythm, it could deliver an unnecessary shock.

Surgeons and electrophysiologists use several strategies to prevent this:

Contralateral placement: The Inspire generator is implanted on the opposite side of the chest from the cardiac device. This maximizes the physical distance between the two pulse generators, which reduces the strength of any electrical signal that travels from one to the other.
Bipolar programming: Cardiac devices can sense in either unipolar or bipolar mode. Bipolar sensing picks up signals from a much smaller area of tissue, which makes it far less likely to detect stray electrical activity from a device across the chest. In the published studies, all cardiac devices were set to bipolar mode.⁴
Intraoperative testing: During the Inspire implant surgery, the surgical team activates the stimulator while monitoring the cardiac device in real time. They test both unipolar and bipolar stimulation settings on the Inspire to confirm that neither configuration triggers false signals on the pacemaker or ICD.
Post-implant interrogation: After the procedure and during follow-up visits, both devices are checked by their respective specialists to confirm that no interference has developed over time.

The one documented case of interference in the single-center study involved inappropriate mode switching on an Abbott pacemaker despite contralateral placement.⁵ That finding reinforces why ongoing monitoring matters even when the initial implant goes smoothly. The atrial channel on pacemakers can be particularly sensitive to outside electrical noise, and different manufacturers’ devices may respond differently. This is not a set-it-and-forget-it situation; you will need follow-up with both your sleep medicine team and your cardiologist or electrophysiologist.

What Qualifying for Inspire Involves

Whether or not you have a pacemaker, Inspire is not available to everyone with sleep apnea. The standard candidacy criteria require that you have moderate-to-severe obstructive sleep apnea, that you have tried CPAP and either cannot tolerate it or it has not worked, that your body mass index falls below a certain threshold (generally around 35, though this has been gradually expanded in some settings), and that your airway anatomy is suitable.

That last point is checked through a procedure called drug-induced sleep endoscopy, or DISE. While you are sedated, a doctor passes a tiny camera through your nose to watch how your airway collapses during simulated sleep. The airway is assessed at several levels, and one specific pattern rules you out: complete concentric collapse at the level of the soft palate.⁶ This pattern means the soft palate closes in a circular, sphincter-like fashion, which the Inspire device cannot effectively counteract because it works by stimulating the tongue forward, not by opening the palate in all directions. DISE became a mandatory part of the screening process after early research showed that patients with this collapse pattern responded poorly to upper airway stimulation.⁷

For pacemaker patients, the screening process adds extra layers. The electrophysiology team needs to review your cardiac device and determine whether bipolar programming is feasible (it usually is, but certain lead configurations or clinical situations may complicate things). The surgical team needs to plan the chest placement to ensure contralateral positioning, and they need to coordinate the intraoperative testing protocol. This means your evaluation involves more specialists and more visits than it would for someone without a cardiac device, but the process is well-defined at centers experienced with both technologies.

ICDs and Cardiac Resynchronization Therapy Devices

The published feasibility study did not limit enrollment to pacemaker patients. It also included four people with ICDs and one with a cardiac resynchronization therapy (CRT) device.⁴ None of those patients experienced oversensing or inappropriate therapy delivery during follow-up.

ICDs carry an additional layer of concern compared to simple pacemakers because they can deliver high-energy shocks. An inappropriate shock triggered by electrical interference is not just a pacing hiccup; it is a painful and potentially dangerous event. The fact that no such episodes occurred in the available data is reassuring, but the sample size is very small (just four ICD patients in one study, with additional ICD patients in the single-center report). If you have an ICD, your electrophysiologist will likely want to see a clean intraoperative test and will probably schedule more frequent device interrogations after the Inspire is activated.

CRT devices are the most complex of the three, because they use multiple leads to coordinate the heart’s pumping chambers. Only one CRT patient has been reported in the published Inspire-plus-cardiac-device literature, so the evidence is essentially a single case. It worked in that case, but a single data point does not create much confidence on its own. If you have a CRT device and are considering Inspire, expect your care team to be cautious and thorough in the evaluation.

What Happens at Follow-Up

After both devices are implanted, you end up with two separate follow-up schedules. The Inspire device typically needs to be activated about a month after surgery to allow healing, and then its stimulation settings are gradually titrated upward during follow-up sleep studies until it effectively controls your apnea. Your cardiac device, meanwhile, continues on its own follow-up schedule with your electrophysiologist, which usually includes periodic in-office interrogations and, in many cases, remote monitoring.

The important thing is that the two teams communicate. When the Inspire settings are adjusted, your electrophysiology team should know about it because changes in stimulation amplitude or mode could theoretically alter the electrical signature that reaches the cardiac device. Similarly, if your cardiologist needs to reprogram your pacemaker or ICD for clinical reasons, your sleep team should be informed in case the new settings affect how the cardiac device filters out the Inspire signal. In practice, this coordination usually happens through shared medical records and direct communication between the device clinics, but it is worth confirming that your providers are talking to each other rather than assuming it.

The single-center study’s finding of inappropriate mode switching in one patient is a reminder of why this coordination matters.⁵ That kind of issue might not produce obvious symptoms. Mode switching in a pacemaker can cause subtle changes in how you feel during sleep, or it might show up only when the device data is downloaded at a clinic visit. Without regular interrogations, it could go unnoticed.

Alternatives When Inspire Is Not an Option

Not every pacemaker patient will qualify for Inspire, and not every case of device-device interaction can be solved with reprogramming. If Inspire is ruled out for you, whether because of your cardiac device situation, your airway anatomy, your BMI, or another factor, there are other non-CPAP approaches to obstructive sleep apnea.

These include mandibular advancement devices (custom-fitted mouthpieces that hold the lower jaw forward to keep the airway open), positional therapy for people whose apnea occurs mainly when sleeping on their back, upper airway surgeries that reshape the soft tissue of the throat, and lifestyle modifications including weight loss, which can substantially reduce apnea severity in patients who are overweight. Because sleep apnea varies so much from person to person in both its causes and severity, effective treatment often involves combining more than one of these approaches.⁸

It is also worth noting that some patients who initially cannot tolerate CPAP may benefit from trying a different mask style, a different pressure delivery mode (like bilevel or auto-adjusting pressure), or coaching on acclimatization techniques. CPAP remains the first-line treatment for moderate-to-severe sleep apnea because the evidence behind it is extensive. If you abandoned it early because the mask was uncomfortable or the pressure felt too high, a revisit with a sleep specialist who can troubleshoot those specific problems may be worthwhile before pursuing surgery.

The Undiagnosed Sleep Apnea Problem in Pacemaker Patients

One of the more striking findings in this area is not about device compatibility at all but about how many pacemaker patients have sleep apnea and do not know it. The European multicenter study found undiagnosed sleep apnea in 59% of the pacemaker patients it screened, with most of those patients having no classic symptoms beyond snoring.¹ The study using newer pacemaker diagnostics found an even higher rate, at 74%, with most patients again lacking the daytime sleepiness that many people associate with sleep apnea.²

This matters because untreated sleep apnea in a cardiac patient is not just a quality-of-life issue. The repeated oxygen drops and sympathetic nervous system surges that occur with each apnea event place ongoing stress on a heart that is already compromised. If you have a pacemaker and have never been evaluated for sleep apnea, the research suggests it is well worth asking your cardiologist about screening, particularly if you snore or if your partner has noticed pauses in your breathing at night. Whether the eventual treatment turns out to be CPAP, Inspire, a dental device, or something else entirely, identifying the problem is the essential first step.

Newer pacemakers with built-in respiratory sensing algorithms may eventually make screening easier by flagging suspicious breathing patterns automatically during device checks. Some models already have this capability, which is what enabled the 74% detection rate in the pacemaker-based screening study. As this technology matures, the gap between how many pacemaker patients have sleep apnea and how many know about it should start to close.